MedTrace Logo

Oral Huzhang Granules for Acute Gouty Arthritis

NCT04462666 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 267

Last updated 2020-07-08

No results posted yet for this study

Summary

We designed this study as a double-blind, randomized, controlled clinical trial. The aim of the study is to evaluate the clinical efficacy, safety and control of recurrence rate of acute gouty arthritis

Conditions

  • Gouty Arthritis

Interventions

DRUG

Huzhang granule

Empty the content of one sachet into a mug, add 50ml warm water, stir until dissolved, add another 50ml hot water. Consume and complete all 100ml liquid mixture as a single dosage.

DRUG

Etoricoxib

take one capsule per day in the morning, at approximately 30 minutes after the meal.

DRUG

Huzhang granule Placebo

Empty the content of one sachet into a mug, add 50ml warm water, stir until dissolved, add another 50ml hot water. Consume and complete all 100ml liquid mixture as a single dosage.

DRUG

Etoricoxib Placebo

take one capsule per day in the morning, at approximately 30 minutes after the meal.

Sponsors & Collaborators

  • Shanghai Yueyang Integrated Medicine Hospital

    lead OTHER

Principal Investigators

  • Jia Zhou · Shanghai Yueyang Integrated Medicine Hospital, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2023-07-31
Completion
2023-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04462666 on ClinicalTrials.gov